Gossamer Bio Inc.

NASDAQ: GOSS · Real-Time Price · USD
1.97
0.01 (0.51%)
At close: Aug 15, 2025, 3:59 PM
1.95
-0.76%
After-hours: Aug 15, 2025, 07:44 PM EDT

Gossamer Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
40.24M 124.59M 114.7M 112.11M 102.63M 6.78M 6.78M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a 986K 1.99M 3.09M 4.24M 3.26M 3.38M 3.38M 3.33M 4.43M 4.59M 4.79M 4.99M 5.17M 3.88M 2.57M 1.27M
Gross Profit
28.75M 124.59M 113.72M 110.11M 99.53M 2.54M 3.53M -3.38M -3.38M -3.33M -4.43M -4.59M -4.79M -4.99M -5.17M -3.88M -2.57M -1.27M
Operating Income
-145.62M -54.77M -59.92M -72.82M -79.39M -177.78M -183.76M -189.09M -204.62M -212.19M -218.59M -215.9M -215.54M -217.26M -216.12M -224.55M -222.46M -232.2M
Interest Income
1.27M 2.47M 2.52M 2.83M 2.81M 1.75M 2M 2.28M 2.34M 1.95M 1.58M 1.23M 951K 792K 761K 891K 1.28M 2.04M
Pretax Income
-142.28M -50.34M -55.63M -68.34M -76.42M -172.58M -179.82M -187.43M -206.79M -220.76M -229.38M -229.9M -230.78M -234.15M -234M -242.32M -239.89M -246.93M
Net Income
-138.74M -51.24M -56.53M -71.65M -80.85M -172.58M -179.82M -188.85M -211.55M -228.12M -240.18M -239.28M -236.82M -237.59M -234M -242.32M -239.89M -246.93M
Selling & General & Admin
35.23M 35.22M 36.13M 35.8M 36.58M 37.89M 38.45M 42.23M 44.44M 45.74M 47.61M 45.49M 46.45M 46.44M 45.78M 50.95M 49.93M 50.33M
Research & Development
150.63M 144.14M 138.49M 132.34M 128.65M 129.87M 135.27M 146.81M 160.12M 166.39M 170.92M 170.34M 169.02M 170.76M 170.27M 168.25M 166.9M 161.27M
Other Expenses
n/a n/a n/a 10M 10M 10.02M 10.03M 1.49M 1.15M 1.73M 1.51M 134K 581K 451K 799K 591K 476K 19K
Operating Expenses
185.86M 179.36M 174.62M 178.14M 175.23M 177.78M 183.76M 189.07M 204.59M 212.15M 218.53M 215.83M 215.47M 217.2M 216.05M 219.19M 216.84M 211.59M
Interest Expense
5.47M 11.13M 11.52M 12.02M 12.63M 13.14M 13.51M 13.73M 13.86M 13.91M 13.88M 15.36M 16.77M 18.13M 19.44M 19.26M 19.08M 16.74M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
135.6M 179.36M 174.62M 178.14M 175.23M 177.78M 183.76M 189.07M 204.59M 212.15M 218.53M 215.83M 215.47M 217.2M 216.05M 219.19M 216.84M 211.59M
Income Tax Expense
-3.54M 893K 893K 3.3M 4.43M n/a n/a 1.42M 4.76M 7.36M 10.8M 9.38M 6.04M 3.44M n/a n/a n/a n/a
Shares Outstanding (Basic)
227.28M 226.82M 226.6M 226.35M 226.22M 225.74M 225.41M 192.88M 95.45M 94.55M 94.28M 91.18M 76.67M 75.89M 75.59M 75M 74.67M 74.09M
Shares Outstanding (Diluted)
227.28M 226.82M 226.6M 226.35M 238.54M 225.74M 225.41M 192.88M 95.45M 94.87M 94.28M 91.18M 76.67M 75.89M 75.59M 75M 74.67M 74.09M
EPS (Basic)
-0.62 -0.23 -0.26 -0.32 -0.39 -1.06 -1.39 -1.79 -2.27 -2.59 -2.88 -3.01 -3.12 -3.15 -3.12 -3.26 -3.26 -3.46
EPS (Diluted)
-0.62 -0.24 -0.27 -0.33 -0.4 -1.06 -1.39 -1.79 -2.27 -2.59 -2.88 -3.01 -3.12 -3.15 -3.12 -3.26 -3.26 -3.46
EBITDA
-132.04M -35.7M -39.97M -52.24M -59.72M -155.21M -161.92M -169.2M -188.4M -202.37M -211.07M -209.95M -209.22M -211.03M -209.4M -213.88M -211.76M -223.4M
EBIT
-95.79M -39.21M -44.12M -56.33M -63.79M -159.44M -166.31M -173.7M -192.93M -206.84M -215.5M -214.54M -214.01M -216.02M -214.56M -238.12M -236.63M -246.01M
Depreciation & Amortization
2.52M 3.51M 4.15M 4.08M 4.07M 4.23M 4.38M 4.5M 4.52M 4.47M 4.43M 4.59M 4.79M 4.99M 5.17M 5.09M 4.96M 4.65M